Induction of HMOX1 by mesenchymal stem cell cytotherapy inhibits osteoclastogenesis and myeloma-induced bone disease.
Li X, Ling W, Barlogie B, Yaccoby S. Induction of HMOX1 by mesenchymal stem cell cytotherapy inhibits osteoclastogenesis and myeloma-induced bone disease. Clin Transl Med. 2025 May; 15(5):e70302.